Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
3T Biosciences logo — 3T is an immunotherapy company developing next-generation, t...

3T Biosciences

3T is an immunotherapy company developing next-generation, transformative therapies for broad patient populations.

Founded 2017 United States South San Francisco, United States 26 employees Series A Total: $52.00M Biopharma, Biotechnology +1

General Information

Company Name 3T Biosciences
Founded Year 2017
Location United States South San Francisco, United States
Employees 26
Industries Biopharma, Biotechnology, Health Care
Funding Stage Series A
Business Model B2B, B2C, B2D
Revenue Model Licensing, Performance Based, Product Sales
Social

BounceWatch is an independent company data service, not affiliated with 3T Biosciences. To contact 3T Biosciences, visit 3tbiosciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 3T Biosciences compare?

A PDF of 3T Biosciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 3T Biosciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 3T Biosciences

3T Biosciences, founded in 2017 and headquartered in the United States, is an emerging player in the Biopharma and Biotechnology sectors. The company is dedicated to revolutionizing immunotherapy by developing next-generation therapies aimed at treating solid tumors and other immune-mediated diseases. Their unique approach harnesses the immune system's inherent ability to identify and eradicate cancer cells, potentially offering safer and more effective treatments.

Recently, 3T Biosciences secured a $40.00M Series A investment on 01 August 2022, led by prominent investors Lightspeed Venture Partners and Westlake Village BioPartners. This substantial financial backing underscores the investor confidence in the company's cutting-edge technology and its potential to bring transformative solutions to patients with difficult-to-treat cancers.

3T's vision aligns with the growing demand for advanced immunotherapies, positioning it strategically within the evolving Health Care industry.

Business keywords: immunotherapy, next-generation therapies, transformative therapies, solid tumors, immune-mediated diseases, broad patient populations, cancer treatment, immune system leveraging, cell-targeting technology, safer cancer therapies, effective cancer treatments, curative therapies, difficult-to-treat cancers, oncology

Services & Products

Development of transformative therapies
Treatment for solid tumors
Innovative immunotherapy solutions

Target Customers

Patients with solid tumors Broad patient populations Healthcare providers

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $40.00M 2
Lightspeed Venture Partners Westlake Village BioPartners
Lightspeed Venture Partners, Westlake Village BioPartners
01 Aug 2022
Seed $12.00M 1
CRV
CRV
01 Oct 2017
Convertible Note Undisclosed 1
Asset Management Ventures
Asset Management Ventures
01 Feb 2017

3T Biosciences Alternatives & Competitors

View All Alternatives
3T Biosciences vs
Alumis
Alumis United States

Transforming the lives of patients living with immune-mediated diseases using a precision approach.

Series C
249 employees
Biotechnology, Health Care
Compare 3T Biosciences vs Alumis
3T Biosciences vs
Kite Pharma
Kite Pharma United States

At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.

Acquired
4013 employees
Biotechnology, Health Care
Compare 3T Biosciences vs Kite Pharma
3T Biosciences vs
Glycyx
Glycyx United States

Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance immunother...

Series A
3 employees
Biopharma, Biotechnology
Also compare with: 3T Biosciences vs Neogene Therapeutics Neogene Therapeutics 3T Biosciences vs Revitope Revitope View all alternatives

FAQ About 3T Biosciences

3T is an immunotherapy company developing next-generation, transformative therapies for broad patient populations.
3T Biosciences was founded in 2017.
3T Biosciences is headquartered in South San Francisco, United States.
3T Biosciences operates in Biopharma, Biotechnology and Health Care. Its work centres on immunotherapy, next-generation therapies, transformative therapies and solid tumors. Its customers include Patients with solid tumors, Broad patient populations and Healthcare providers.
3T Biosciences has a B2B, B2C and B2D business model. Its revenue comes from Licensing, Performance Based and Product Sales.
3T Biosciences has approximately 26 employees.
3T Biosciences has completed 3 funding rounds, raising a total of $52.00M. The latest funding stage is Series A.
3T Biosciences offers: Development of transformative therapies, Treatment for solid tumors, Innovative immunotherapy solutions.
Top alternatives and competitors to 3T Biosciences include Alumis, Kite Pharma, Glycyx, TScan Therapeutics, Neogene Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
3T Biosciences and Alumis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for 3T Biosciences, https://bouncewatch.com/company/3t-biosciences, updated 4 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes